Food and Drug Safety Policy Changes in 2021

[Enhance the development, supply and safety monitoring of COVID-19 medicines]
Expand infrastructure for the swift supply of COVID-19 vaccines and therapeutics
Establish criteria for the review and categorization of highly advanced biopharmaceuticals

[Re-design the foundation for food safety in preparation of future changes]
Allow food service establishments to provide outdoor services
Institutionalize shared-kitchen business activities
Enforce functionality labeling requirements for conventional foods
Strengthen the management of ground meat to enhance food safety (e.g. hamburger patties)

[Create reliable and healthy dietary environment for children]
Address blind spots in the hygiene and nutrition management of meal services for children
Expand nutritional labeling requirements for hamburgers sold in small- and medium-sized franchises

[Expand the digital infrastructure to take a life-cycle approach in the safety management of imported foods]
Introduce remote inspection system for foreign food establishments
Expand safety inspection on foods purchased directly from overseas and ban the sales and customs clearance of non-compliant products
Provide information on imported foods through mobile devices

[Create a pharmaceutical environment that ensures the safety of the people of Korea]
Conduct integrated and expedited reviews of clinical data through institutional review boards designated by the government
Utilize various real-world data from medical practices in pharmacovigilance
Operate the Quality by Design system for pharmaceuticals

[Promote the growth of the cosmetics industry by boosting the customized cosmetics business]
Expand job opportunities for customized cosmetics preparation manager
Refine the regulations regarding the sales of customized cosmetics

[Revamp medical device regulations and safeguard people's right to health]
Allow changes in the intended purpose of medical device for displays
Implement a certification system for the producers of software for innovative medical devices
Mandate the reporting of the cessation of production of medical devices